Tags: India
Ashok Vemuri resigns from Infosys board
Despite being next in line as chief executive of Infosys Ltd, Ashok Vemuri resigned from the company's board.
ONGC to increase overseas debt for USD2.64 billion acquisition
India's ONGC Videsh said it would increase its overseas debt to fund a USD2.64 acquisition. ONGC Videsh Ltd. is a state-backed energy explorer in India.
PE exits doubled in India, IT sector leading
Private equity exits in India had doubled amid the weakened currency, unstable market capital and poor macro-economic conditions.
SBI expects INR4 billion in capital infusion
The State Bank of India announced that it had expected to receive a total of INR4 billion in recapitalization from the government.
Latest News
Infosys, the largest software services exporter in India appointed three new members on its executive council.
Despite the current market trends in India, a total of six small and medium enterprises had filed IPOs in the last one month.
Royal DSM announced plans of slowly transferring back-office work to India in the next couple of years.
Car manufacturers increased production as rise in sales of petrol driven cars in India continue. In India, demand for petrol cars increased after a 25-month hiatus.
Cheraman Financial Services announced today a proposed plan of funding different infrastructure projects in Kerala.
Prime Minister Manmohan Singh of India said the country will not replaying the crisis that occurred in 1991 even as it experiences its slowest growth in a decade.
India's INS Sindhurakshak exploded in Mumbai, killing up to 18 sailors trapped inside. India's Russian-made naval submarine exploded while moored in Mumbai.
Google would launch 'Google Impact Challenge in India' and award an Rs 3 crore worth about US$500,000 and technical assistance that would bring the winning projects into life.
India announced the activation of the atomic reactor of its first nuclear submarine, a first step for the completion of its nuclear triad.
The personal genomic and biotechnology corporation in the US would target people's DNA by selling their genetic information for US$99.